This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pharmathen S.a.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Panagiotis Mparmpalexis: Innovator in Pharmaceutical Composition
Introduction
Panagiotis Mparmpalexis is a notable inventor based in Pallini Attikis, Greece. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance patient care. His work focuses on creating effective solutions that address specific medical needs.
Latest Patents
Mparmpalexis holds a patent for a pharmaceutical composition containing a phosphate binding polymer. This invention relates to a fast dissolving tablet that comprises a therapeutically effective amount of a phosphate binding polymer, such as sevelamer or its pharmaceutically acceptable salts or derivatives. The tablet is designed to exhibit limited swelling in the oral cavity, provide a pleasant taste and mouth feel, and possess a high phosphate binding capacity with fast binding kinetics. Additionally, it requires a limited amount of water intake for optimal effectiveness.
Career Highlights
Panagiotis Mparmpalexis is associated with Pharmathen S.A., a company known for its commitment to pharmaceutical innovation. His work at Pharmathen has allowed him to contribute to the development of advanced therapeutic solutions that improve patient outcomes. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Mparmpalexis has collaborated with notable colleagues, including Evangelos Karavas and Efthimios Koutris. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.
Conclusion
Panagiotis Mparmpalexis is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact patient care. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile